Floatz logo

Fludarabine

Shwachman-Diamond Syndrome

Fred Hutchinson Cancer CenterSmall moleculePhase 2/3Active
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Shwachman-Diamond Syndrome cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Roswell Park Cancer Institute
Phase 2/3BB
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 2/3BB
METHOTREXATE
Fred Hutchinson Cancer Center
Phase 2B
Equine Atg
Masonic Cancer Center, University of Minnesota
Phase 2/3B
TACROLIMUS
Fred Hutchinson Cancer Center
Phase 2B

View all 13 →

Same molecule, other indications

Fludarabine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi anemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Adult Diffuse Large Cell LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →